Evidence map›Paper›PMID 32668667›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Functional Analysis of the

David L Lin, German M Traglia, Rachel Baker, David J Sherratt, Maria Soledad Ramirez, Marcelo E Tolmasky

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. DiverseMicrobiology spectrum · 2026
    Article
  4. Bovine-DerivedMicroorganisms · 2026
    Article
  5. Article
  6. ChromosomalFrontiers in microbiology · 2025
    Article
  7. A strain defined as a novel species in theFrontiers in cellular and infection microbiology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Identification of Mobile Colistin Resistance GeneAntibiotics (Basel, Switzerland) · 2022
    Article
  12. GR13-type plasmids inMicrobial genomics · 2022
    Article
  13. Comparative Genomic Analysis of SevenFrontiers in microbiology · 2022
    Article
  14. Article
  15. Article
  16. Molecular Epidemiology of Extensively Drug-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Whole-Genome Assessment of ClinicalFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

David L LinCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA 92831, USA.
German M TragliaDepartamento de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Universidad de la República (UDeLaR), Montevideo 11600, Uruguay.
Rachel BakerDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
David J SherrattDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.ORCID 0000-0002-2104-5430
Maria Soledad RamirezCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA 92831, USA.ORCID 0000-0002-9904-7890
Marcelo E TolmaskyCenter for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA 92831, USA.ORCID 0000-0002-6298-7811
California State University, Fullerton · USUniversity of Oxford · GBUniversidad de la República de Uruguay · UY

Funding

Minority Health and Health Disparities International Research Training ProgramT37MD001368 · NIMHD · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2005 to 2024
$3.9M
DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGYR15AI047115 · NIAID · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2000 to 2022
$1.8M
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter sppSC3GM125556 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI RAMIREZ, MARIA SOLEDAD · 2018 to 2025
$851k
Biotechnology and Biological Sciences Research Council BB/I004785/1National Institute of Allergy and Infectious Diseases 2R15AI047115National Institute of Minority Health and Health Disparities T37MD001368NIAID NIH HHS R15 AI047115NIGMS NIH HHS SC3GM125556NIMHD NIH HHS T37 MD001368Wellcome Trust 200782/Z/16/Z
6 · The paper itself

Abstract

Modules composed of a resistance gene flanked by Xer site-specific recombination sites, the vast majority of which were found in

Indexed as

AcinetobactercarbapenemasedifESKAPEgene disseminationgene transferhorizontal disseminationhorizontal transferpdifplasmidRe27site-specific recombinationXer

Identifiers

PMID32668667
PMCPMC7399989
OpenAlexW3035204695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.